S. No. |
Antimicrobial |
Type of Response |
Gr. I Control |
Gr. II |
Gr. III
Day 10 |
Day 5 |
Day 10 |
1. |
Amikacin |
S |
S |
S |
S |
2. |
Amoxicillin/ K-clavulanate |
R |
R |
R |
R |
3. |
Ampicillin/Sulbactam |
R |
R |
R |
R |
4. |
Ampicillin |
R |
R |
R |
R |
5. |
Aztreonam |
R |
R |
R |
IB |
6. |
Cafazolin |
R |
R |
R |
R |
7. |
Cefepime |
S |
S |
S |
S |
8. |
Cefotaxime |
IB |
I |
I |
IB |
9. |
Cefotetan |
R |
R |
R |
R |
10. |
Cefoxitin |
R |
R |
R |
R |
11. |
Ceftazidime |
I |
I |
I |
IB |
12. |
Ceftriaxone |
IB |
I |
I |
IB |
13. |
Cefuroxime |
R |
R |
R |
R |
14. |
Cephalothin |
R |
R |
R |
R |
15. |
Chloramphenicol |
S |
S |
S |
S |
16. |
Ciprofloxacin |
I |
I |
I |
S |
17. |
Gatifloxacin |
S |
S |
S |
S |
18. |
Gentamicin |
S |
S |
S |
S |
19. |
Imipenem |
S |
S |
S |
S |
20. |
Levofloxacin |
S |
S |
S |
S |
21. |
Meropenem |
S |
S |
S |
S |
22. |
Moxifloxacin |
S |
S |
S |
S |
23. |
Piperacillin |
IB |
IB |
IB |
IB |
24. |
Piperacillin/Tazobactam |
IB |
IB |
IB |
IB |
25. |
Tetracycline |
S |
S |
S |
S |
26. |
Ticarcillin/K-Clavulanate |
R |
I |
I |
I |
27. |
Tobramycin |
S |
S |
S |
S |
28. |
Trimethoprim/Sulfamethoxazole |
S |
S |
S |
S |
R: Resistant; I: Intermediate; S: Susceptible; IB: reduced activity of inducible β-lactamase;
Gr.: Group |
|